Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Am J Transplant. 2016 Jun 15;16(8):2377–2383. doi: 10.1111/ajt.13847

Figure 1.

Figure 1

Risk of graft loss by exposure category (HIV-infection and HCV-infection). Models were adjusted for the following: recipient age, race, HCV status, HLA mismatches, PRA, history of diabetes, donor age, and donor race. HCV, hepatitis C virus; HIV, human immunodeficiency virus; HLA, human leukocyte antigen; PRA, panel-reactive antibody.